Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-06

FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental abbreviated new drug application for lurasidone hydrochloride, enabling marketing of the generic product with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lurasidone hydrochloride (Lurasidone hydrochloride)

Snippet

SUPPL AP for LURASIDONE HYDROCHLORIDE (LURASIDONE HYDROCHLORIDE)